The company's customer wins this year suggest more revenue expansion to come. In fact, C3.ai forecasts fiscal 2026 sales to ...

The U.S. Food and Drug Administration has granted approval to Empaveli as the primary treatment for C3 glomerulopathy .The drug has received approval for patients over 12 years and above who work to ...

The affected products were sold by retailers including Argos, B&M, DID, Lidl, Poundland, Robert Dyas, Tesco, and the Tower ...